The board has declared 3rd interim dividend for FY 2024-25 of 85% cash reward for shareholders. A dividend is always ...

A BSE 200 stock today approved the financial results (Standalone and Consolidated) for the third quarter and nine months of ...

India's Larsen & Toubro reported a third-quarter profit miss on Thursday, and said its quarterly order growth quickened ...

India's Adani Enterprises , the flagship company of the Adani group, reported a slump in third-quarter profit on Thursday, ...

Brookfield real estate investment trust (REIT) reported an annual increase of 11 per cent in its net operating income (NOI) ...

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the ...

A redesigned third-generation Audi Q3 is set to debut soon, and prototypes of its coupe-like Sportback body style have been ...

Maran Partners Fund returned +6.4% (net); the full-year 2024 return was +16.0% net. Click here to read the full letter.

L&T stock price has remained weak in the past one year. While L&T shares are down 3% in one month, they have fallen 8% in six months and over 4% in one year.

The financial advisory firm's quarterly results significantly surpassed expectations.

B. Sees Q3 Productivity and Business Processes revenue $29.4B-$29.7B. Sees Q3 Office 365 growth mid teens. Sees Q3 Azure revenue growth 31%-32%. Sees Q3 CapEx similar to Q2. Sees Q3 currency impacting ...

Shares of Biocon Ltd closed slightly higher at ₹357.15 on the BSE today, up 0.44% or ₹1.55, ahead of the earnings announcement.